In 2023, the spectral cell analyzers market is expected to be worth US$ 1.5 billion. The market is expected to reach US$ 3.0 billion by 2033, expanding at a 7.2% CAGR throughout the forecast period. The spectral cell analyzers industry is driven by rising demand in research and clinical applications. Immunology, cancer research, drug development, and clinical …